{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:33:27Z","timestamp":1773297207753,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1002\/jps.20025","type":"journal-article","created":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T08:00:41Z","timestamp":1078128041000},"page":"1054-1061","source":"Crossref","is-referenced-by-count":30,"title":["Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane\u2010based metered dose inhalers"],"prefix":"10.1016","volume":"93","author":[{"given":"Paul B.","family":"Myrdal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly L.","family":"Karlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve W.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1002\/jps.20025_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002512-200320040-00006","article-title":"Novel drug delivery systems for insulin: Clinical potential for use in the elderly","volume":"20","author":"Belmin","year":"2003","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1002\/jps.20025_bb0015","first-page":"833","article-title":"Syringe, pen, inhaler: The evolution of insulin therapy","volume":"7","author":"Harsch","year":"2001","journal-title":"Med Sci Monit"},{"issue":"9","key":"10.1002\/jps.20025_bb0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2337\/diacare.23.9.1343","article-title":"Intra\u2010individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer","volume":"23","author":"Heinemann","year":"2000","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/jps.20025_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/PDT-120000290","article-title":"Pulmonary peptide delivery: Effect of taste\u2010masking excipients on leuprolide suspension metered\u2010dose inhalers","volume":"6","author":"Zheng","year":"2001","journal-title":"Pharm Dev Technol"},{"key":"10.1002\/jps.20025_bb0030","first-page":"735","article-title":"Developmental pharmaceutics of inhaled peptides and proteins. Inhalation delivery of therapeutic peptides and proteins","volume":"107","author":"Adjei","year":"1997","journal-title":"Lung Biol Health Dis"},{"key":"10.1002\/jps.20025_bb0035","first-page":"281","article-title":"Cyclosporine. Inhalation delivery of therapeutic peptides and proteins","volume":"107","author":"Burckart","year":"1997","journal-title":"Lung Biol Health Dis"},{"key":"10.1002\/jps.20025_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/rr58","article-title":"The lung as a route for systemic delivery of therapeutic proteins and peptides","volume":"2","author":"Agu","year":"2001","journal-title":"Respir Res"},{"key":"10.1002\/jps.20025_bb0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/rmed.2002.1457","article-title":"Fundamentals of pulmonary drug delivery","volume":"97","author":"Groneberg","year":"2003","journal-title":"Respir Med"},{"key":"10.1002\/jps.20025_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-3659(96)01579-9","article-title":"Peptide delivery via the pulmonary route: A valid approach for local and systemic delivery","volume":"46","author":"Smith","year":"1997","journal-title":"J Control Release"},{"key":"10.1002\/jps.20025_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(97)00506-1","article-title":"Preparation of peptide and protein powders for inhalation","volume":"26","author":"Johnson","year":"1997","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1002\/jps.20025_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)90070-1","article-title":"Drug delivery to the respiratory tract using dry powder inhalers","volume":"101","author":"Timsina","year":"1994","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20025_bb0065","first-page":"379","article-title":"Recent advances in pulmonary drug delivery using large, porous inhaled particles","volume":"85","author":"Edwards","year":"1998","journal-title":"J Appl Phys"},{"issue":"7","key":"10.1002\/jps.20025_bb0070","first-page":"52","article-title":"5 Myths about MDIs","volume":"2","author":"Brown","year":"2002","journal-title":"Drug Deliv"},{"issue":"11","key":"10.1002\/jps.20025_bb0075","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1023\/A:1012118132241","article-title":"Tetrafluoroethane (HFC 134a) propellant\u2010driven aerosols of proteins","volume":"14","author":"Brown","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20025_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0928-0987(98)00015-3","article-title":"Formulation of a protein with propellant HFA 134a for aerosol delivery","volume":"7","author":"Williams","year":"1998","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20025_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5173(98)00266-X","article-title":"Investigation of a pMDI system containing chitosan microspheres and P134a","volume":"174","author":"Williams","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20025_bb0090","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0041-1345(98)00800-8","article-title":"The case for local immunosuppression in composite tissue allotransplantation","volume":"30","author":"Shirbacheh","year":"1998","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1002\/jps.20025_bb0095","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1053-2498(00)00176-5","article-title":"In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine","volume":"19","author":"Mitruka","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/jps.20025_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)00975-X","article-title":"Effects of cyclosporin A administered into the airways against antigen\u2010induced airway inflammation and hyperreactivity in the rat","volume":"420","author":"Underwood","year":"2001","journal-title":"Eur J Pharm"},{"key":"10.1002\/jps.20025_bb0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/009127000004001106","article-title":"Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients","volume":"40","author":"Rohatagi","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1002\/jps.20025_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1023\/A:1022275222207","article-title":"Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients","volume":"20","author":"Burckart","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20025_bb0115","series-title":"Respiratory drug delivery VIII","first-page":"663","article-title":"Evaluation of a new aerodynamic particle sizer for MDI distribution measurements","author":"Myrdal","year":"2002"},{"key":"10.1002\/jps.20025_bb0120","first-page":"3065","article-title":"Physical tests and determinations \u3008601\u3009 aerosols, metered dose inhalers, and dry powders","volume":"22","year":"1996","journal-title":"Pharmac Forum"},{"key":"10.1002\/jps.20025_bb0125","series-title":"Respiratory drug delivery VIII","first-page":"659","article-title":"Comparison of the TSI model 3306 impactor inlet with the Andersen Cascade Impactor; solution metered dose inhalers","author":"Gupta","year":"2002"},{"key":"10.1002\/jps.20025_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9673(96)00770-4","article-title":"High\u2010performance liquid chromatographic analysis of cyclosporin A and its oral solutions","volume":"759","author":"Husek","year":"1997","journal-title":"J Chromatogr A"},{"issue":"2","key":"10.1002\/jps.20025_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/089426803321919870","article-title":"Evaluation of a new aerodynamic particle sizer spectrometer for size distribution measurement of solution metered dose inhalers","volume":"16","author":"Stein","year":"2003","journal-title":"J Aerosol Med"},{"issue":"2","key":"10.1002\/jps.20025_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/089426803321919924","article-title":"Balancing ethanol cosolvent concentration with product performance in 134a\u2010based pressurized metered dose inhalers","volume":"16","author":"Gupta","year":"2003","journal-title":"J Aerosol Med"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916314630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916314630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T01:37:33Z","timestamp":1682645853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916314630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0022354916314630"],"URL":"https:\/\/doi.org\/10.1002\/jps.20025","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}